Skip to main content
SpringerLink
Log in

Plasma somatostatin-like immunoreactivity and somatostatin-28 levels in obese men

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Somatostatin (SS) impairs nutrient absorption. It has been suggested that hyposomatostatinaemia may be involved in the pathogenesis of obesity. However, data on postprandial SS-like immunoreactivity (SLI) levels in obese subjects are controversial and the levels of SS-28, the main molecular form of circulating SLI in healthy subjects, have not been determined. To characterise the fasting and postprandial plasma pattern of SLI and SS-28 in obese men, we studied eight obese men (age 24–32 yr, BMI 33–42 kg/m2), with normal glucose tolerance test and normal gastric emptying of solids, and eight healthy men (age 24–39 yr, BMI 21–24 kg/m2). Blood samples were taken at regular intervals in fasting conditions and for 2 h after a standard solid-liquid meal (2.3 MJ). Plasma SLI and SS-28 were measured by RIA. Our results showed that fasting and postprandial plasma SLI and SS-28 levels were not significantly different in healthy and obese subjects. In conclusion SS-28 is the predominant form of circulating SLI in obese subjects. The normal pattern of fasting and postprandial plasma SLI and SS-28 levels in such subjects suggests that somatostatin does not have a pathogenetic role in obesity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Shulkes A. Somatostatin: physiology and clinical applications. Baillières Clin. Endocrinol. Metab. 8: 215, 1994.

    Article  PubMed  CAS  Google Scholar 

  2. Schusdziarra V., Schmid R. Physiological and pathophysiological aspects of somatostatin. Scand. J. Gastroenterol. 21(suppl 119): 29, 1986.

    Article  Google Scholar 

  3. Krejs G.J. Physiological role of somatostatin in the digestive tract: gastric acid secretion, intestinal absorption, and motility. Scand. J. Gastroenterol. 21(suppl 119): 47, 1986.

    Article  Google Scholar 

  4. Schusdziarra V., Zyznar E., Rouiller D., Boden G., Brown J.C., Arimura A., Unger R.H. Splanchnic somatostatin: a hormonal regulator of nutrient homeostasis. Science 207: 530, 1980.

    Article  PubMed  CAS  Google Scholar 

  5. Schusdziarra V., Lawecki J., Ditschuneit H.H., Lukas B., Maier V., Pfeiffer E.F. Effect of low-dose somatostatin infusion on pancreatic and gastric endocrine function in lean and obese nondiabetic human subjects. Diabetes 34: 595, 1985.

    Article  PubMed  CAS  Google Scholar 

  6. Sasaki H., Nagulesparan M., Dubois A., Vasquez B., Johnson G.C., Sievers M.L., Unger R.H. Hyperinsulinemia in obesity: lack of relation to gastric emptying of glucose solution or to plasma somatostatin levels. Metabolism 32: 701, 1983.

    Article  PubMed  CAS  Google Scholar 

  7. Granstrom L., Backman L., Uvnas-Moberg K. Serum gastrin, insulin and somatostatin levels in normal and obese subjects before and after gastric banding. Acta Chir. Scand. 154: 117, 1988.

    PubMed  CAS  Google Scholar 

  8. Barreca T., Franceschini R., Messina V., Cataldi A., Salvemini M., Rolandi E. Plasma somatostatin and vasoactive intestinal polypetide responses to an oral mixed test meal in obese patients. Horm. Res. 31: 234, 1989.

    Article  PubMed  CAS  Google Scholar 

  9. Wisen O., Bjorvell H., Cantor P., Johansson C., Theodorsson E. Plasma concentrations of regulatory peptides in obesity following modified sham feeding and a liquid test meal. Regul. Pept. 39: 43, 1992.

    Article  PubMed  CAS  Google Scholar 

  10. Pirke K.M., Frieß E., Kellner M.B., Krieg J.C., Fichter M.M. Somatostatin in eating disorders. Int. J. Eating Dis. 15: 99, 1994.

    Article  CAS  Google Scholar 

  11. Shoelson S.E., Polonsky K.S., Nakabayashi T., Jaspan J.B., Tager H.S. Circulating forms of somatostatin like immunoreactivity in human plasma. Am. J. Physiol. 250: E428, 1986.

    PubMed  CAS  Google Scholar 

  12. Ensinck J.W., Laschansky E.C., Vogel R.E., Simonowitz D.A., Roos B.A., Francis B.H. Circulating prosomatostatin-derived peptides. Differential responses to food ingestion. J. Clin. Invest. 83: 1580, 1989.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  13. Elashoff J.D., Reedy T.J., Meyer J.H. Analysis of gastric emptying data. Gastroenterology 83: 1306, 1982.

    PubMed  CAS  Google Scholar 

  14. Polonsky K.S., Shoelson S.E., Docherty H.M. Plasma somatostatin 28 increase in response to feeding in man. J. Clin. Invest. 71: 1514, 1983.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  15. D’Alessio D.A., Ensinck J.W. Fasting and postprandial concentrations of somatostatin-28 and somatostatin-14 in type II diabetes in men. Diabetes 39: 1198, 1990.

    Article  PubMed  Google Scholar 

  16. Ensinck J.W., Vogel R.E., Laschansky E.C., Francis B.C. Effect of ingested carbohydrate, fat and protein on the release of somatostatin-28 in humans. Gastroenterology 98: 633, 1990.

    PubMed  CAS  Google Scholar 

  17. Hutson W.R., Wald A. Obesity and weight reduction do not influence gastric emptying and antral motility. Am. J. Gastroenterol. 88: 1405, 1993.

    PubMed  CAS  Google Scholar 

  18. Wright R.A., Krinsky S., Fleeman C., Trujillo J., Teague E. Gastric emptying and obesity. Gastroenterology 83: 747, 1983.

    Google Scholar 

  19. Horowitz M., Collins P.J., Cook D.J., Harding P.E., Shearman D.J.C. Abnormalities of gastric emptying in obese patients. Int. J. Obes. 7: 415, 1983.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Istituto di Scienze Mediche, Università di Milano, IRCCS-Ospedale Maggiore di Milano, Padiglione Granelli, Via F. Sforza 35, 20122, Milano, Italy

    Maddalena Peracchi M.D., F. Carola, B. Bareggi & G. Basilisco

  2. II Cattedra di Endocrinologia, Università di Milano, Istituto Scientifico Ospedale S. Luca, Milano, Italy

    F. Cavagnini

  3. Servizio di Medicina Nucleare, IRCCS-Ospedale Maggiore di Milano, Milano, Italy

    R. Benti

  4. Istituto Scientifico Ospedale S. Giuseppe, Piancavallo, Verbania, Italy

    G. Baccalaro

Authors
  1. Maddalena Peracchi M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Carola
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F. Cavagnini
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. Benti
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. B. Bareggi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G. Baccalaro
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. G. Basilisco
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Peracchi, M., Carola, F., Cavagnini, F. et al. Plasma somatostatin-like immunoreactivity and somatostatin-28 levels in obese men. J Endocrinol Invest 21, 20–23 (1998). https://doi.org/10.1007/BF03347281

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03347281

Key-words

Search

Navigation